Inactive Instrument

FS Development Corp.

FSDC

US3030201012

FS Development Corp.(NasdaqCM:FSDC) added to NASDAQ Composite Index

August 13, 2020 at 09:30 am

FS Development Corp. has been added to NASDAQ Composite Index .

Latest news about FS Development Corp.

Certain Class B Common Stock of FS Development Corp. are subject to a Lock-Up Agreement Ending on 7-FEB-2021.	21-02-06	CI
FS Development Corp.(NasdaqCM:FSDC) dropped from NASDAQ Composite Index	21-02-05	CI
Gemini Therapeutics, Inc. completed the acquisition of FS Development Corp. in a reverse merger transaction.	21-02-04	CI
Gemini Therapeutics and FS Development Corp. Announces Management Appointments for the Combined Company	20-10-15	CI
Gemini Therapeutics, Inc. entered into a definitive merger agreement to acquire FS Development Corp. for approximately $240 million in a reverse merger transaction.	20-10-14	CI
FS Development Corp. Announces Board Appointments	20-08-14	CI
FS Development Corp. announced that it has received $4.415 million in funding from FS Development Holdings, LLC	20-08-13	CI
FS Development Corp.(NasdaqCM:FSDC) added to NASDAQ Composite Index	20-08-13	CI
FS Development Corp. has completed an IPO in the amount of $105 million.	20-08-11	CI
FS Development Corp. has filed an IPO in the amount of $100 million.	20-07-24	CI
FS Development Corp. announced that it expects to receive $4 million in funding from FS Development Holdings, LLC	20-07-23	CI

FS Development Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses for target business in the biotechnology sector. The Company has no business operations and has not generated any revenues.

Sector

More about the company